Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-05 · accession 0001674236-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-05 | 2026-03-05 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale+OE | $75.50 | -7,312 | 189.5K | -4% | -$552.0K |
| D | 2026-03-05 | 2026-03-05 | ANIP | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | +3,312 | 192.9K | +2% | +$164.0K |
| D | 2026-03-05 | 2026-03-05 | ANIP | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | -3,312 | 9,938 | -25% | -$164.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-05 | S | D | 4,000 | $75.56 | 185,543 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-05 | M | A | 3,312 | $49.51 | 192,855 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-05 | S | D | 3,312 | $75.42 | 189,543 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $75.41 to $75.56. The price reported above reflects the weighted average sales price. |
| 4 | Derivative | Stock Option (right to buy) | 2026-03-05 | M | D | 3,312 | $49.51 | 9,938 | D | $49.51 · — to 2027-03-30 | 3,312 Common Stock | (F2) 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. |